State of Wisconsin Investment Board’s Summit Therapeutics SMMT Stock Holding History

State of Wisconsin Investment Board’s Portfolio SMMT Stock Details SMMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$261K	Sell	17,897 -44,638	-71%	-$792K	﹤0.01%	2320
2026 Q1	$1.19M	Sell	62,535 -30,347	-33%	-$491K	﹤0.01%	1615
2025 Q4	$1.62M	Buy	92,882 +1,047	+1%	+$19.7K	﹤0.01%	1492
2025 Q3	$1.9M	Buy	+91,835	New	+$2.23M	﹤0.01%	1384
2025 Q2	–	Sell	-44,364	Closed	-$856K	–	2410
2025 Q1	$856K	Sell	44,364 -5,188	-10%	-$104K	﹤0.01%	1540
2024 Q4	$884K	Buy	49,552 +38,509	+349%	+$746K	﹤0.01%	1578
2024 Q3	$242K	Buy	+11,043	New	+$154K	﹤0.01%	2115
2024 Q2	–	Sell	-102,394	Closed	-$424K	–	2378
2024 Q1	$424K	Sell	102,394 -13,097	-11%	-$52.1K	﹤0.01%	1835
2023 Q4	$301K	Sell	115,491 -3,779	-3%	-$7.77K	﹤0.01%	2010
2023 Q3	$223K	Sell	119,270 -14,062	-11%	-$26.8K	﹤0.01%	2196
2023 Q2	$335K	Buy	+133,332	New	+$243K	﹤0.01%	1960
2021 Q4	–	Sell	-29,100	Closed	-$146K	–	2205
2021 Q3	$146K	Buy	29,100 +18,458	+173%	+$132K	﹤0.01%	2091
2021 Q2	$79K	Buy	+10,642	New	+$69.8K	﹤0.01%	2057

Other funds holding SMMT

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

State of Wisconsin Investment Board's SMMT Position: Q2 2026 in Review

State of Wisconsin Investment Board reduced its Summit Therapeutics (SMMT) stake by 71% in Q2 2026, selling an estimated $792K and leaving 17,897 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #2320.

State of Wisconsin Investment Board first reported a position in SMMT in Q2 2021 and has held it in 13 quarters since. The position peaked at $1.9M in Q3 2025. 243 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

State of Wisconsin Investment Board held 17,897 shares of Summit Therapeutics worth $261K as of Q2 2026.
State of Wisconsin Investment Board sold 44,638 Summit Therapeutics shares in Q2 2026, an estimated $792K.
Summit Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #2320 holding.
State of Wisconsin Investment Board first reported a position in Summit Therapeutics in Q2 2021 and has held it in 13 quarters since.
State of Wisconsin Investment Board's Summit Therapeutics position peaked at $1.9M in Q3 2025.
243 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.